Clinical Trial Update: Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cabozantinib in patients with refractory metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Academic Thoracic Oncology Medical Investigators Consortium | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-02